25 XP   0   0   10

Beijing Hotgen Biotech Co Ltd
Buy, Hold or Sell?

Let's analyse Hotgen together

PenkeI guess you are interested in Beijing Hotgen Biotech Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Beijing Hotgen Biotech Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Beijing Hotgen Biotech Co Ltd

I send you an email if I find something interesting about Beijing Hotgen Biotech Co Ltd.

Quick analysis of Hotgen (30 sec.)










What can you expect buying and holding a share of Hotgen? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
77.8%

What is your share worth?

Current worth
¥36.89
Expected worth in 1 year
¥34.97
How sure are you?
88.9%

+ What do you gain per year?

Total Gains per Share
¥-1.91
Return On Investment
-6.4%

For what price can you sell your share?

Current Price per Share
¥29.85
Expected price per share
¥23.67 - ¥34.08
How sure are you?
50%

1. Valuation of Hotgen (5 min.)




Live pricePrice per Share (EOD)

¥29.85

Intrinsic Value Per Share

¥37.61 - ¥41.85

Total Value Per Share

¥74.50 - ¥78.74

2. Growth of Hotgen (5 min.)




Is Hotgen growing?

Current yearPrevious yearGrowGrow %
How rich?$470m$460.6m$8.6m1.8%

How much money is Hotgen making?

Current yearPrevious yearGrowGrow %
Making money-$3.5m$62.5m-$66m-1,868.6%
Net Profit Margin-1.3%37.5%--

How much money comes from the company's main activities?

3. Financial Health of Hotgen (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#121 / 1007

Most Revenue
#34 / 1007

Most Profit
#25 / 1007

Most Efficient
#64 / 1007

What can you expect buying and holding a share of Hotgen? (5 min.)

Welcome investor! Hotgen's management wants to use your money to grow the business. In return you get a share of Hotgen.

What can you expect buying and holding a share of Hotgen?

First you should know what it really means to hold a share of Hotgen. And how you can make/lose money.

Speculation

The Price per Share of Hotgen is ¥29.85. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hotgen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hotgen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥36.89. Based on the TTM, the Book Value Change Per Share is ¥-0.48 per quarter. Based on the YOY, the Book Value Change Per Share is ¥3.87 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hotgen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.05-0.2%0.030.1%0.682.3%0.291.0%0.291.0%
Usd Book Value Change Per Share-0.04-0.1%-0.07-0.2%0.531.8%0.280.9%0.280.9%
Usd Dividend Per Share0.000.0%0.000.0%0.351.2%0.120.4%0.120.4%
Usd Total Gains Per Share-0.04-0.1%-0.07-0.2%0.883.0%0.411.4%0.411.4%
Usd Price Per Share5.40-6.60-14.81-9.89-9.89-
Price to Earnings Ratio-29.70-26.38-5.84-265.14-265.14-
Price-to-Total Gains Ratio-134.39-18.87-21.86-418.19-418.19-
Price to Book Ratio1.06-1.30-3.00-4.39-4.39-
Price-to-Total Gains Ratio-134.39-18.87-21.86-418.19-418.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.122285
Number of shares242
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.12
Usd Book Value Change Per Share-0.070.28
Usd Total Gains Per Share-0.070.41
Gains per Quarter (242 shares)-15.9898.05
Gains per Year (242 shares)-63.91392.20
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-64-74118274382
20-128-138236548774
30-192-2023558221166
40-256-26647310961558
50-320-33059113701950
60-384-39470916442342
71-448-45882819182734
81-512-52294621923126
91-576-586106424663518
101-640-650118227403910

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%17.01.00.094.4%17.01.00.094.4%17.01.00.094.4%
Book Value Change Per Share2.02.00.050.0%9.03.00.075.0%13.05.00.072.2%13.05.00.072.2%13.05.00.072.2%
Dividend per Share1.00.03.025.0%9.00.03.075.0%14.00.04.077.8%14.00.04.077.8%14.00.04.077.8%
Total Gains per Share2.02.00.050.0%10.02.00.083.3%16.02.00.088.9%16.02.00.088.9%16.02.00.088.9%

Fundamentals of Hotgen

About Beijing Hotgen Biotech Co Ltd

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins. Beijing Hotgen Biotech Co., Ltd. was founded in 2005 and is based in Beijing, China.

Fundamental data was last updated by Penke on 2024-04-18 17:50:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Beijing Hotgen Biotech Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hotgen earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hotgen to the Biotechnology industry mean.
  • A Net Profit Margin of -30.4% means that ¥-0.30 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Beijing Hotgen Biotech Co Ltd:

  • The MRQ is -30.4%. The company is making a huge loss. -2
  • The TTM is -1.3%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-30.4%TTM-1.3%-29.1%
TTM-1.3%YOY37.5%-38.8%
TTM-1.3%5Y18.7%-20.0%
5Y18.7%10Y18.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-30.4%-207.2%+176.8%
TTM-1.3%-216.8%+215.5%
YOY37.5%-282.4%+319.9%
5Y18.7%-426.4%+445.1%
10Y18.7%-589.3%+608.0%
1.1.2. Return on Assets

Shows how efficient Hotgen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hotgen to the Biotechnology industry mean.
  • -0.8% Return on Assets means that Hotgen generated ¥-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Beijing Hotgen Biotech Co Ltd:

  • The MRQ is -0.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.8%TTM-0.6%-0.2%
TTM-0.6%YOY11.9%-12.6%
TTM-0.6%5Y6.9%-7.6%
5Y6.9%10Y6.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.8%-13.0%+12.2%
TTM-0.6%-12.5%+11.9%
YOY11.9%-11.2%+23.1%
5Y6.9%-13.6%+20.5%
10Y6.9%-15.2%+22.1%
1.1.3. Return on Equity

Shows how efficient Hotgen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hotgen to the Biotechnology industry mean.
  • -0.9% Return on Equity means Hotgen generated ¥-0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Beijing Hotgen Biotech Co Ltd:

  • The MRQ is -0.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM-0.8%-0.1%
TTM-0.8%YOY14.2%-15.0%
TTM-0.8%5Y9.1%-9.9%
5Y9.1%10Y9.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.9%-16.6%+15.7%
TTM-0.8%-15.7%+14.9%
YOY14.2%-14.2%+28.4%
5Y9.1%-18.9%+28.0%
10Y9.1%-19.9%+29.0%

1.2. Operating Efficiency of Beijing Hotgen Biotech Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hotgen is operating .

  • Measures how much profit Hotgen makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hotgen to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Beijing Hotgen Biotech Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.1%-5.1%
TTM5.1%YOY40.4%-35.3%
TTM5.1%5Y27.1%-21.9%
5Y27.1%10Y27.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--285.4%+285.4%
TTM5.1%-226.2%+231.3%
YOY40.4%-288.4%+328.8%
5Y27.1%-469.6%+496.7%
10Y27.1%-599.3%+626.4%
1.2.2. Operating Ratio

Measures how efficient Hotgen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.86 means that the operating costs are ¥1.86 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Beijing Hotgen Biotech Co Ltd:

  • The MRQ is 1.864. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.425. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.864TTM1.425+0.438
TTM1.425YOY1.059+0.366
TTM1.4255Y1.201+0.224
5Y1.20110Y1.2010.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8643.231-1.367
TTM1.4253.303-1.878
YOY1.0593.763-2.704
5Y1.2015.586-4.385
10Y1.2017.464-6.263

1.3. Liquidity of Beijing Hotgen Biotech Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hotgen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.51 means the company has ¥5.51 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Beijing Hotgen Biotech Co Ltd:

  • The MRQ is 5.506. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.782. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.506TTM4.782+0.724
TTM4.782YOY5.461-0.679
TTM4.7825Y6.256-1.474
5Y6.25610Y6.2560.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.5063.855+1.651
TTM4.7824.160+0.622
YOY5.4615.323+0.138
5Y6.2566.122+0.134
10Y6.2566.480-0.224
1.3.2. Quick Ratio

Measures if Hotgen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hotgen to the Biotechnology industry mean.
  • A Quick Ratio of 2.23 means the company can pay off ¥2.23 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Beijing Hotgen Biotech Co Ltd:

  • The MRQ is 2.234. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.051. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.234TTM2.051+0.182
TTM2.051YOY2.714-0.662
TTM2.0515Y2.675-0.624
5Y2.67510Y2.6750.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2343.506-1.272
TTM2.0514.001-1.950
YOY2.7145.390-2.676
5Y2.6756.127-3.452
10Y2.6756.488-3.813

1.4. Solvency of Beijing Hotgen Biotech Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hotgen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hotgen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.06 means that Hotgen assets are financed with 5.6% credit (debt) and the remaining percentage (100% - 5.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Beijing Hotgen Biotech Co Ltd:

  • The MRQ is 0.056. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.087. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.056TTM0.087-0.032
TTM0.087YOY0.132-0.045
TTM0.0875Y0.139-0.052
5Y0.13910Y0.1390.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0560.344-0.288
TTM0.0870.339-0.252
YOY0.1320.275-0.143
5Y0.1390.368-0.229
10Y0.1390.389-0.250
1.4.2. Debt to Equity Ratio

Measures if Hotgen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hotgen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 5.9% means that company has ¥0.06 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Beijing Hotgen Biotech Co Ltd:

  • The MRQ is 0.059. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.098. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.059TTM0.098-0.039
TTM0.098YOY0.158-0.060
TTM0.0985Y0.177-0.079
5Y0.17710Y0.1770.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0590.390-0.331
TTM0.0980.408-0.310
YOY0.1580.341-0.183
5Y0.1770.438-0.261
10Y0.1770.469-0.292

2. Market Valuation of Beijing Hotgen Biotech Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hotgen generates.

  • Above 15 is considered overpriced but always compare Hotgen to the Biotechnology industry mean.
  • A PE ratio of -29.70 means the investor is paying ¥-29.70 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Beijing Hotgen Biotech Co Ltd:

  • The EOD is -22.659. Based on the earnings, the company is expensive. -2
  • The MRQ is -29.704. Based on the earnings, the company is expensive. -2
  • The TTM is 26.384. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD-22.659MRQ-29.704+7.044
MRQ-29.704TTM26.384-56.088
TTM26.384YOY5.840+20.544
TTM26.3845Y265.138-238.753
5Y265.13810Y265.1380.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-22.659-2.351-20.308
MRQ-29.704-2.599-27.105
TTM26.384-2.762+29.146
YOY5.840-4.025+9.865
5Y265.138-6.305+271.443
10Y265.138-6.538+271.676
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Beijing Hotgen Biotech Co Ltd:

  • The EOD is -6.693. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.773. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 6.416. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-6.693MRQ-8.773+2.081
MRQ-8.773TTM6.416-15.189
TTM6.416YOY-41.734+48.150
TTM6.4165Y-26.928+33.344
5Y-26.92810Y-26.9280.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.693-3.010-3.683
MRQ-8.773-3.306-5.467
TTM6.416-3.607+10.023
YOY-41.734-5.524-36.210
5Y-26.928-8.299-18.629
10Y-26.928-8.910-18.018
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hotgen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.06 means the investor is paying ¥1.06 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Beijing Hotgen Biotech Co Ltd:

  • The EOD is 0.809. Based on the equity, the company is cheap. +2
  • The MRQ is 1.061. Based on the equity, the company is underpriced. +1
  • The TTM is 1.300. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.809MRQ1.061-0.252
MRQ1.061TTM1.300-0.239
TTM1.300YOY3.003-1.703
TTM1.3005Y4.393-3.093
5Y4.39310Y4.3930.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.8092.019-1.210
MRQ1.0612.116-1.055
TTM1.3002.099-0.799
YOY3.0032.873+0.130
5Y4.3933.556+0.837
10Y4.3933.946+0.447
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Beijing Hotgen Biotech Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.291-0.479+64%3.866-108%2.049-114%2.049-114%
Book Value Per Share--36.88836.825+0%36.149+2%22.113+67%22.113+67%
Current Ratio--5.5064.782+15%5.461+1%6.256-12%6.256-12%
Debt To Asset Ratio--0.0560.087-36%0.132-58%0.139-60%0.139-60%
Debt To Equity Ratio--0.0590.098-40%0.158-63%0.177-67%0.177-67%
Dividend Per Share---0.001-100%2.528-100%0.884-100%0.884-100%
Eps---0.3290.196-268%4.907-107%2.105-116%2.105-116%
Free Cash Flow Per Share---1.115-1.490+34%4.051-128%1.204-193%1.204-193%
Free Cash Flow To Equity Per Share---1.115-1.535+38%2.104-153%0.619-280%0.619-280%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--41.848--------
Intrinsic Value_10Y_min--37.610--------
Intrinsic Value_1Y_max--7.362--------
Intrinsic Value_1Y_min--7.233--------
Intrinsic Value_3Y_max--19.704--------
Intrinsic Value_3Y_min--18.860--------
Intrinsic Value_5Y_max--29.136--------
Intrinsic Value_5Y_min--27.251--------
Market Cap2754223680.000-31%3610478144.0004411602000.000-18%9892604005.440-64%6611112830.862-45%6611112830.862-45%
Net Profit Margin---0.304-0.013-96%0.375-181%0.187-263%0.187-263%
Operating Margin---0.051-100%0.404-100%0.271-100%0.271-100%
Operating Ratio--1.8641.425+31%1.059+76%1.201+55%1.201+55%
Pb Ratio0.809-31%1.0611.300-18%3.003-65%4.393-76%4.393-76%
Pe Ratio-22.659+24%-29.70426.384-213%5.840-609%265.138-111%265.138-111%
Price Per Share29.850-31%39.13047.813-18%107.215-64%71.651-45%71.651-45%
Price To Free Cash Flow Ratio-6.693+24%-8.7736.416-237%-41.734+376%-26.928+207%-26.928+207%
Price To Total Gains Ratio-102.517+24%-134.38818.870-812%21.860-715%418.193-132%418.193-132%
Quick Ratio--2.2342.051+9%2.714-18%2.675-17%2.675-17%
Return On Assets---0.008-0.006-24%0.119-107%0.069-112%0.069-112%
Return On Equity---0.009-0.008-13%0.142-106%0.091-110%0.091-110%
Total Gains Per Share---0.291-0.478+64%6.394-105%2.934-110%2.934-110%
Usd Book Value--470040567.406469232746.236+0%460619818.995+2%281767729.600+67%281767729.600+67%
Usd Book Value Change Per Share---0.040-0.066+64%0.534-108%0.283-114%0.283-114%
Usd Book Value Per Share--5.0945.085+0%4.992+2%3.054+67%3.054+67%
Usd Dividend Per Share---0.000-100%0.349-100%0.122-100%0.122-100%
Usd Eps---0.0450.027-268%0.678-107%0.291-116%0.291-116%
Usd Free Cash Flow---14208371.940-18990443.260+34%51618398.794-128%15336689.551-193%15336689.551-193%
Usd Free Cash Flow Per Share---0.154-0.206+34%0.559-128%0.166-193%0.166-193%
Usd Free Cash Flow To Equity Per Share---0.154-0.212+38%0.291-153%0.085-280%0.085-280%
Usd Market Cap380358290.208-31%498607031.686609242236.200-18%1366168613.151-64%912994681.942-45%912994681.942-45%
Usd Price Per Share4.122-31%5.4046.603-18%14.806-64%9.895-45%9.895-45%
Usd Profit---4196526.951-3535149.200-16%62522569.299-107%25568992.014-116%25568992.014-116%
Usd Revenue--13797531.14332946832.542-58%158221471.080-91%76872549.069-82%76872549.069-82%
Usd Total Gains Per Share---0.040-0.066+64%0.883-105%0.405-110%0.405-110%
 EOD+3 -5MRQTTM+20 -15YOY+9 -265Y+8 -2710Y+8 -27

3.2. Fundamental Score

Let's check the fundamental score of Beijing Hotgen Biotech Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-22.659
Price to Book Ratio (EOD)Between0-10.809
Net Profit Margin (MRQ)Greater than0-0.304
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.234
Current Ratio (MRQ)Greater than15.506
Debt to Asset Ratio (MRQ)Less than10.056
Debt to Equity Ratio (MRQ)Less than10.059
Return on Equity (MRQ)Greater than0.15-0.009
Return on Assets (MRQ)Greater than0.05-0.008
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Beijing Hotgen Biotech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.117
Ma 20Greater thanMa 5029.172
Ma 50Greater thanMa 10030.888
Ma 100Greater thanMa 20034.587
OpenGreater thanClose29.350
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Minority Interest  9,53513,93723,472-20,6832,7882,7965,584-6,511-927
Operating Income  306,331-295,69810,63436,96247,595-26,47821,118-65,290-44,172
Interest Income  9,47944,31553,794-44,4589,33619,36628,702-61,264-32,562



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,604,263
Total Liabilities200,639
Total Stockholder Equity3,400,983
 As reported
Total Liabilities 200,639
Total Stockholder Equity+ 3,400,983
Total Assets = 3,604,263

Assets

Total Assets3,604,263
Total Current Assets931,272
Long-term Assets2,672,991
Total Current Assets
Cash And Cash Equivalents 194,109
Short-term Investments 274,336
Net Receivables 103,473
Inventory 135,495
Other Current Assets 154,892
Total Current Assets  (as reported)931,272
Total Current Assets  (calculated)862,305
+/- 68,967
Long-term Assets
Property Plant Equipment 1,114,966
Intangible Assets 54,250
Long-term Assets Other 96,295
Long-term Assets  (as reported)2,672,991
Long-term Assets  (calculated)1,265,511
+/- 1,407,480

Liabilities & Shareholders' Equity

Total Current Liabilities169,142
Long-term Liabilities31,497
Total Stockholder Equity3,400,983
Total Current Liabilities
Short Long Term Debt 6,677
Accounts payable 113,045
Other Current Liabilities 644
Total Current Liabilities  (as reported)169,142
Total Current Liabilities  (calculated)120,367
+/- 48,775
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt12,597
Long-term Liabilities  (as reported)31,497
Long-term Liabilities  (calculated)12,597
+/- 18,899
Total Stockholder Equity
Retained Earnings 2,986,504
Total Stockholder Equity (as reported)3,400,983
Total Stockholder Equity (calculated)2,986,504
+/- 414,479
Other
Capital Stock92,269
Common Stock Shares Outstanding 92,269
Net Invested Capital 3,407,660
Net Working Capital 762,130
Property Plant and Equipment Gross 1,114,966



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
> Total Assets 
288,372
698,029
725,675
754,703
706,203
686,024
902,515
2,342,242
2,579,983
2,401,130
3,644,845
3,921,781
3,855,707
3,928,415
3,899,272
3,703,811
3,701,105
3,604,263
3,604,2633,701,1053,703,8113,899,2723,928,4153,855,7073,921,7813,644,8452,401,1302,579,9832,342,242902,515686,024706,203754,703725,675698,029288,372
   > Total Current Assets 
137,665
545,044
549,219
567,293
505,446
451,189
587,771
1,980,473
2,065,818
1,779,047
2,517,680
2,338,990
2,245,664
2,216,954
1,798,269
1,354,547
1,195,303
931,272
931,2721,195,3031,354,5471,798,2692,216,9542,245,6642,338,9902,517,6801,779,0472,065,8181,980,473587,771451,189505,446567,293549,219545,044137,665
       Cash And Cash Equivalents 
43,644
438,053
422,849
53,040
56,800
40,970
382,625
825,519
484,174
316,760
1,161,060
651,464
671,119
627,248
523,493
319,263
325,876
194,109
194,109325,876319,263523,493627,248671,119651,4641,161,060316,760484,174825,519382,62540,97056,80053,040422,849438,05343,644
       Short-term Investments 
1,900
0
0
352,554
279,664
238,148
0
544,000
1,231,942
1,086,854
927,446
1,054,510
976,980
1,105,083
888,685
448,560
308,160
274,336
274,336308,160448,560888,6851,105,083976,9801,054,510927,4461,086,8541,231,942544,0000238,148279,664352,554001,900
       Net Receivables 
26,801
22,388
42,279
57,177
58,330
52,180
35,076
85,720
61,454
76,473
77,153
161,320
116,968
75,074
95,801
124,402
142,875
103,473
103,473142,875124,40295,80175,074116,968161,32077,15376,47361,45485,72035,07652,18058,33057,17742,27922,38826,801
       Inventory 
46,255
55,668
66,172
79,354
99,139
98,111
126,311
346,746
170,425
174,129
258,623
346,523
331,909
254,723
154,249
148,635
132,106
135,495
135,495132,106148,635154,249254,723331,909346,523258,623174,129170,425346,746126,31198,11199,13979,35466,17255,66846,255
       Other Current Assets 
5,925
7,457
17,919
25,167
11,513
21,780
43,760
178,489
117,823
124,831
93,399
125,173
98,688
154,826
82,259
313,688
76,286
154,892
154,89276,286313,68882,259154,82698,688125,17393,399124,831117,823178,48943,76021,78011,51325,16717,9197,4575,925
   > Long-term Assets 
150,707
152,985
176,456
187,410
200,757
234,835
314,744
361,769
514,165
622,083
1,127,164
1,582,791
1,610,042
1,711,461
2,101,003
2,349,264
2,505,802
2,672,991
2,672,9912,505,8022,349,2642,101,0031,711,4611,610,0421,582,7911,127,164622,083514,165361,769314,744234,835200,757187,410176,456152,985150,707
       Property Plant Equipment 
0
134,072
150,481
162,445
173,821
202,007
237,378
283,591
381,639
447,290
562,116
628,256
699,907
784,338
867,939
995,858
1,079,955
1,114,966
1,114,9661,079,955995,858867,939784,338699,907628,256562,116447,290381,639283,591237,378202,007173,821162,445150,481134,0720
       Intangible Assets 
949
10,476
1,331
10,624
1,418
20,315
58,450
57,870
57,223
58,095
57,333
57,215
56,420
55,626
56,553
55,759
54,879
54,250
54,25054,87955,75956,55355,62656,42057,21557,33358,09557,22357,87058,45020,3151,41810,6241,33110,476949
       Long-term Assets Other 
2,909
2,571
6,234
6,080
3,913
204,732
5,206
5,298
21,371
25,215
27,846
49,931
24,927
29,868
76,205
92,940
92,116
96,295
96,29592,11692,94076,20529,86824,92749,93127,84625,21521,3715,2985,206204,7323,9136,0806,2342,5712,909
> Total Liabilities 
63,605
72,454
76,375
105,486
73,862
51,440
155,723
994,000
451,377
247,585
771,015
431,683
458,294
348,125
545,589
300,509
270,614
200,639
200,639270,614300,509545,589348,125458,294431,683771,015247,585451,377994,000155,72351,44073,862105,48676,37572,45463,605
   > Total Current Liabilities 
42,012
50,600
45,522
74,542
63,743
41,403
144,113
955,127
422,162
221,099
734,161
393,264
419,399
311,715
511,307
264,591
239,762
169,142
169,142239,762264,591511,307311,715419,399393,264734,161221,099422,162955,127144,11341,40363,74374,54245,52250,60042,012
       Short Long Term Debt 
0
3,889
2,500
2,500
0
0
0
0
8,094
7,277
12,999
10,966
9,815
9,634
27,949
9,850
12,294
6,677
6,67712,2949,85027,9499,6349,81510,96612,9997,2778,09400002,5002,5003,8890
       Accounts payable 
10,517
8,646
6,260
14,493
14,632
18,679
66,241
263,180
118,214
109,106
177,504
181,248
88,059
154,806
263,443
156,534
63,599
113,045
113,04563,599156,534263,443154,80688,059181,248177,504109,106118,214263,18066,24118,67914,63214,4936,2608,64610,517
       Other Current Liabilities 
4,093
3,889
18,879
51,175
39,196
13,645
41,246
646,704
224,092
54,794
421,800
51,029
218,751
84,569
1,443
76,515
136,211
644
644136,21176,5151,44384,569218,75151,029421,80054,794224,092646,70441,24613,64539,19651,17518,8793,8894,093
   > Long-term Liabilities 
21,594
21,854
30,853
30,944
10,119
10,037
11,610
38,873
29,215
26,486
36,854
38,419
38,895
36,410
34,283
35,917
30,852
31,497
31,49730,85235,91734,28336,41038,89538,41936,85426,48629,21538,87311,61010,03710,11930,94430,85321,85421,594
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
25,263
15,785
13,175
22,978
24,543
20,515
17,733
14,183
15,818
10,396
12,597
12,59710,39615,81814,18317,73320,51524,54322,97813,17515,78525,2630000000
       Long-term Liabilities Other 
21,073
21,111
21,250
21,250
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000021,25021,25021,11121,073
       Deferred Long Term Liability 
0
5,282
7,682
7,263
10,814
8,191
10,558
11,544
8,735
18,725
22,316
21,450
36,333
27,953
23,203
22,428
20,986
0
020,98622,42823,20327,95336,33321,45022,31618,7258,73511,54410,5588,19110,8147,2637,6825,2820
> Total Stockholder Equity
223,405
624,645
645,157
645,644
629,097
631,221
742,729
1,344,062
2,116,217
2,139,766
2,843,525
3,450,350
3,351,821
3,539,521
3,335,224
3,387,633
3,428,778
3,400,983
3,400,9833,428,7783,387,6333,335,2243,539,5213,351,8213,450,3502,843,5252,139,7662,116,2171,344,062742,729631,221629,097645,644645,157624,645223,405
   Common Stock
0
62,196
62,196
62,196
62,196
62,196
62,196
62,196
62,196
62,196
62,196
62,196
92,051
92,051
0
92,051
92,269
0
092,26992,051092,05192,05162,19662,19662,19662,19662,19662,19662,19662,19662,19662,19662,1960
   Retained Earnings 
104,598
106,378
137,439
137,951
120,733
123,853
230,846
832,171
1,590,170
1,613,891
2,323,315
2,929,277
2,827,113
3,113,845
2,911,902
3,016,811
3,062,917
2,986,504
2,986,5043,062,9173,016,8112,911,9023,113,8452,827,1132,929,2772,323,3151,613,8911,590,170832,171230,846123,853120,733137,951137,439106,378104,598
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
-11
-26
-51
27
-101
-161
-152
-237
-408
-295
569
-303
148
-27
-18
-379
0
0-379-18-27148-303569-295-408-237-152-161-10127-51-26-110



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue954,289
Cost of Revenue-464,710
Gross Profit489,579489,579
 
Operating Income (+$)
Gross Profit489,579
Operating Expense-919,115
Operating Income35,174-429,536
 
Operating Expense (+$)
Research Development152,031
Selling General Administrative289,998
Selling And Marketing Expenses-
Operating Expense919,115442,029
 
Net Interest Income (+$)
Interest Income40,599
Interest Expense--
Other Finance Cost-3,374
Net Interest Income37,225
 
Pretax Income (+$)
Operating Income35,174
Net Interest Income37,225
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-170,94735,174
EBIT - interestExpense = 0
-102,394
-102,394
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--170,947
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-170,947
Tax Provision--37,636
Net Income From Continuing Ops-133,311-133,311
Net Income-102,394
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--37,225
 

Technical Analysis of Hotgen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hotgen. The general trend of Hotgen is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hotgen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Beijing Hotgen Biotech Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 29.60 < 31.77 < 34.08.

The bearish price targets are: 26.85 > 23.67.

Tweet this
Beijing Hotgen Biotech Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Beijing Hotgen Biotech Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Beijing Hotgen Biotech Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Beijing Hotgen Biotech Co Ltd. The current macd is -0.676491.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hotgen price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hotgen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hotgen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Beijing Hotgen Biotech Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBeijing Hotgen Biotech Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Beijing Hotgen Biotech Co Ltd. The current adx is 24.04.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hotgen shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Beijing Hotgen Biotech Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Beijing Hotgen Biotech Co Ltd. The current sar is 26.90.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Beijing Hotgen Biotech Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Beijing Hotgen Biotech Co Ltd. The current rsi is 52.12. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Beijing Hotgen Biotech Co Ltd Daily Relative Strength Index (RSI) ChartBeijing Hotgen Biotech Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Beijing Hotgen Biotech Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hotgen price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Beijing Hotgen Biotech Co Ltd Daily Stochastic Oscillator ChartBeijing Hotgen Biotech Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Beijing Hotgen Biotech Co Ltd. The current cci is 22.18.

Beijing Hotgen Biotech Co Ltd Daily Commodity Channel Index (CCI) ChartBeijing Hotgen Biotech Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Beijing Hotgen Biotech Co Ltd. The current cmo is 19.91.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Beijing Hotgen Biotech Co Ltd Daily Chande Momentum Oscillator (CMO) ChartBeijing Hotgen Biotech Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Beijing Hotgen Biotech Co Ltd. The current willr is -17.3553719.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Beijing Hotgen Biotech Co Ltd Daily Williams %R ChartBeijing Hotgen Biotech Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Beijing Hotgen Biotech Co Ltd.

Beijing Hotgen Biotech Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Beijing Hotgen Biotech Co Ltd. The current atr is 1.04573913.

Beijing Hotgen Biotech Co Ltd Daily Average True Range (ATR) ChartBeijing Hotgen Biotech Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Beijing Hotgen Biotech Co Ltd. The current obv is -5,760,409.

Beijing Hotgen Biotech Co Ltd Daily On-Balance Volume (OBV) ChartBeijing Hotgen Biotech Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Beijing Hotgen Biotech Co Ltd. The current mfi is 60.55.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Beijing Hotgen Biotech Co Ltd Daily Money Flow Index (MFI) ChartBeijing Hotgen Biotech Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Beijing Hotgen Biotech Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Beijing Hotgen Biotech Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Beijing Hotgen Biotech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.117
Ma 20Greater thanMa 5029.172
Ma 50Greater thanMa 10030.888
Ma 100Greater thanMa 20034.587
OpenGreater thanClose29.350
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hotgen with someone you think should read this too:
  • Are you bullish or bearish on Hotgen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hotgen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Beijing Hotgen Biotech Co Ltd

I send you an email if I find something interesting about Beijing Hotgen Biotech Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Beijing Hotgen Biotech Co Ltd.

Receive notifications about Beijing Hotgen Biotech Co Ltd in your mailbox!